Neuroendocrine Regulation and Metabolism of Glucose and Lipids in Primary Chronic Insomnia: A Prospective Case-Control Study

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Seelig, Eleonora ^a   Keller, Ulrich ^a   Klarhöfer, Markus ^a   Scheffler, Klaus ^a,b   Brand, Serge ^c   Holsboer Trachsler, Edith ^c   Hatzinger, Martin ^c   Bilz, Stefan ^d  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b MAX PLANCK INSTITUTE FOR BIOLOGICAL CYBERNETICS   (Germany)

^c UNIVERSITY OF BASEL   (Switzerland)

^d Kantonsspital St Gallen ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; GLUCOSE; HYDROCORTISONE; LIPID; METADRENALIN;

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY COMPOSITION; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOCRINE DISEASE; FAT CONTENT; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HORMONE BLOOD LEVEL; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSOMNIA; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID BLOOD LEVEL; LIPID METABOLISM; NEUROENDOCRINE SYSTEM; NONALCOHOLIC FATTY LIVER; POLYSOMNOGRAPHY; PRIMARY CHRONIC INSOMNIA; PROSPECTIVE STUDY; SALIVA ANALYSIS; URINE LEVEL;

BODY COMPOSITION; CASE-CONTROL STUDIES; CATECHOLAMINES; ELECTRIC IMPEDANCE; ENERGY METABOLISM; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYDROCORTISONE; HYPERINSULINISM; LIPID METABOLISM; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; METANEPHRINE; MIDDLE AGED; MUSCLES; NEUROSECRETORY SYSTEMS; POLYSOMNOGRAPHY; PROSPECTIVE STUDIES; REST; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84876070872     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061780     Document Type: Article

References (33)

1. Ogden CL, Flegal KM, Carroll MD, Johnson CL, (2002) Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 288: 1728-1732.
2. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL, (1998) Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 22: 39-47.
3. Knutson KL, Spiegel K, Penev P, Van Cauter E, (2007) The metabolic consequences of sleep deprivation. Sleep Med Rev 11: 163-178.
4. Staels B (2006) When the Clock stops ticking, metabolic syndrome explodes. Nature Medicine 12: 54-55; discussion 55.
5. Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, et al. (2005) Obesity and metabolic syndrome in circadian Clock mutant mice. Science 308: 1043-1045.
6. Spiegel K, Leproult R, Van Cauter E, (1999) Impact of sleep debt on metabolic and endocrine function. Lancet 354: 1435-1439.
7. Harsch IA, Schahin SP, Radespiel-Troger M, Weintz O, Jahreiss H, et al. (2004) Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. American Journal of Respiratory and Critical Care Medicine 169: 156-162.
8. Cappuccio FP, D'Elia L, Strazzullo P, Miller MA, (2010) Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 33: 414-420.
9. Tasali E, Mokhlesi B, Van Cauter E, (2008) Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 133: 496-506.
10. Spiegel K, Tasali E, Leproult R, Van Cauter E, (2009) Effects of poor and short sleep on glucose metabolism and obesity risk. Nature Reviews Endocrinology 5: 253-261.
11. Ohayon MM, (1997) Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing insomnia related to mental disorders from sleep disorders. J Psychiatr Res 31: 333-346.
12. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J,et al. (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 Suppl 20: 22-33;quiz 34-57.
13. Steer RA, Cavalieri TA, Leonard DM, Beck AT, (1999) Use of the Beck Depression Inventory for Primary Care to screen for major depression disorders. Gen Hosp Psychiatry 21: 106-111.
14. Rechtschaffen A, Kaels A (1968) A Manual Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Bethesda NIH publication 204.
15. Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, et al. (1999) Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 276: E977-989.
16. Longo R, Pollesello P, Ricci C, Masutti F, Kvam BJ, et al. (1995) Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 5: 281-285.
17. Boesch C, Machann J, Vermathen P, Schick F, (2006) Role of proton MR for the study of muscle lipid metabolism. NMR Biomed 19: 968-988.
18. Machann J, Haring H, Schick F, Stumvoll M, (2004) Intramyocellular lipids and insulin resistance. Diabetes Obes Metab 6: 239-248.
19. DeFronzo RA, Tobin JD, Andres R, (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-223.
20. Krystal AD, Edinger JD, (2008) Measuring sleep quality. Sleep Med 9Suppl 1: S10-17.
21. Leproult R, Copinschi G, Buxton O, Van Cauter E, (1997) Sleep loss results in an elevation of cortisol levels the next evening. Sleep 20: 865-870.
22. Kumari M, Badrick E, Ferrie J, Perski A, Marmot M, et al. (2009) Self-reported sleep duration and sleep disturbance are independently associated with cortisol secretion in the Whitehall II study. J Clin Endocrinol Metab 94: 4801-4809.
23. Brand S, Furlano R, Sidler M, Schulz J, Holsboer-Trachsler E, (2011) 'Oh, baby, please don't cry!': in infants suffering from infantile colic hypothalamic-pituitary-adrenocortical axis activity is related to poor sleep and increased crying intensity. Neuropsychobiology 64: 15-23.
24. Holsboer F, von Bardeleben U, Steiger A, (1988) Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man. Neuroendocrinology 48: 32-38.
25. Buckley TM, Schatzberg AF, (2005) On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. The Journal of Clinical Endocrinology and Metabolism 90: 3106-3114.
26. Han KS, Kim L, Shim I, (2012) Stress and sleep disorder. Experimental Neurobiology 21: 141-150.
27. Gottlieb DJ, Punjabi NM, Newman AB, Resnick HE, Redline S, et al. (2005) Association of sleep time with diabetes mellitus and impaired glucose tolerance. Archives of Internal Medicine 165: 863-867.
28. Rafalson L, Donahue RP, Stranges S, Lamonte MJ, Dmochowski J, et al. (2010) Short sleep duration is associated with the development of impaired fasting glucose: the Western New York Health Study. Annals of Epidemiology 20: 883-889.
29. West SD, Nicoll DJ, Stradling JR, (2006) Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax 61: 945-950.
30. Buxton OM, Pavlova M, Reid EW, Wang W, Simonson DC, et al. (2010) Sleep restriction for 1 week reduces insulin sensitivity in healthy men. Diabetes 59: 2126-2133.
31. Keckeis M, Lattova Z, Maurovich-Horvat E, Beitinger PA, Birkmann S, et al. (2010) Impaired glucose tolerance in sleep disorders. PloS One 5: e9444.
32. Nedeltcheva AV, Kessler L, Imperial J, Penev PD, (2009) Exposure to recurrent sleep restriction in the setting of high caloric intake and physical inactivity results in increased insulin resistance and reduced glucose tolerance. The Journal of Clinical Endocrinology and Metabolism 94: 3242-3250.
33. Plat L, Leproult R, L'Hermite-Baleriaux M, Fery F, Mockel J, et al. (1999) Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. The Journal of Clinical Endocrinology and Metabolism 84: 3082-3092.